During the past decade, Japanese Red Cross Kyoto Daiichi Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Japanese Red Cross Kyoto Daiichi Hospital" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Kyoto Prefectural University of Medicine" with 2 trials sponsored, "Chugai Pharmaceutical" with 1 trials sponsored, "Hokuriku-Kinki Immunochemotherapy Study Group" with 1 trials sponsored and "JIMRO Co., Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Japanese Red Cross Kyoto Daiichi Hospital" #1 collaborator was "Japan Lung Cancer Society" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Japanese Red Cross Kyoto Daiichi Hospital" are "Migraine" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Ischemic Stroke" (1 trials), "Acute Myocardial Infarction" (1 trials) and "Angina Pectoris" (1 trials). Many other conditions were trialed in "Japanese Red Cross Kyoto Daiichi Hospital" in a lesser frequency.

Most popular intervention types in "Japanese Red Cross Kyoto Daiichi Hospital" are "Drug" (6 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lasmiditan" (2 trials), "Blopress (Candesartan)" (1 trials), "Krestin (PSK)" (1 trials), "Micardis (Telmisartan)" (1 trials) and "Pitavastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Japanese Red Cross Kyoto Daiichi Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Japanese Red Cross Kyoto Daiichi Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Japanese Red Cross Kyoto Daiichi Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Japanese Red Cross Kyoto Daiichi Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".